Advocates for Duchenne Muscular Dystrophy Start Company Designed to Collect Data Directly From Patients
According to a story from Xconomy, the US Food and Drug Administration (FDA) made a controversial decision three years ago when it approved the drug eteplirsen as a treatment for…